<HTML>
<HEAD>
<TITLE>Filed by Bowne Pure Compliance</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<DIV
style="margin-left: 0.25in; width: 7.2in; font-family: 'Times New Roman',Times,serif">
<DIV style="font-size: 10pt">
<DIV
style="font-size: 1pt; width: 100%; border-bottom: black 2pt solid">&nbsp;</DIV>
<DIV
style="font-size: 1pt; width: 100%; border-bottom: black 1pt solid">&nbsp;</DIV>

<P style="font-size: 14pt" align="center"><B>UNITED STATES<BR>
SECURITIES AND
EXCHANGE COMMISSION<BR>
<FONT style="font-size: 12pt">Washington, D.C. 20549
</FONT></B>

<P style="font-size: 18pt" align="center"><B>FORM 8-K</B>

<P style="font-size: 12pt" align="center"><B>CURRENT REPORT<BR>
Pursuant to
Section 13 or 15(d) of the Securities Exchange Act of 1934</B>

<P style="font-size: 10pt" align="center"><B>Date of Report (Date of earliest
event reported): November 26, 2008</B>


<P style="font-size: 24pt" align="center"><B>EPICEPT CORPORATION<BR>
</B><FONT
style="font-size: 10pt">(Exact name of registrant as specified in its charter)
</FONT>
<TABLE style="font-size: 10pt; text-align: center" cellspacing="0"
cellpadding="0" width="100%" border="0">

 <TR>
  <TD width="32%">&nbsp;</TD>
  <TD width="1%">&nbsp;</TD>
  <TD width="33%">&nbsp;</TD>
  <TD width="1%">&nbsp;</TD>
  <TD width="32%">&nbsp;</TD>
 </TR>
 <TR valign="bottom">
  <TD style="border-bottom: #000000 1px solid"><B>Delaware</B></TD>
  <TD>&nbsp;</TD>
  <TD style="border-bottom: #000000 1px solid"><B>000-51290</B></TD>
  <TD>&nbsp;</TD>
  <TD style="border-bottom: #000000 1px solid"><B>52-1841431</B></TD>
 </TR>
 <TR valign="top">
  <TD>(State or other Jurisdiction of Incorporation)</TD>
  <TD>&nbsp;</TD>
  <TD>(Commission File Number)</TD>
  <TD>&nbsp;</TD>
  <TD>(IRS Employer Identification No.)</TD>
 </TR>

</TABLE>
<TABLE style="font-size: 10pt; text-align: center" cellspacing="0"
cellpadding="0" width="100%" border="0">

 <TR>
  <TD width="49%">&nbsp;</TD>
  <TD width="1%">&nbsp;</TD>
  <TD width="49%">&nbsp;</TD>
 </TR>
 <TR valign="bottom">
  <TD style="border-bottom: #000000 1px solid"><B>777 Old Saw Mill River
Road<BR>
Tarrytown, New York<BR>
</B></TD>
  <TD>&nbsp;</TD>
  <TD style="border-bottom: #000000 1px solid"><B>10591</B></TD>
 </TR>
 <TR valign="top">
  <TD>(Address of Principal Executive Offices)</TD>
  <TD>&nbsp;</TD>
  <TD>(Zip Code)</TD>
 </TR>

</TABLE>


<P style="font-size: 10pt" align="center">Registrant&#8217;s telephone number,
including area code: <B>(914) 606-3500</B>
<TABLE style="font-size: 10pt; text-align: center" cellspacing="0"
cellpadding="0" width="30%" border="0">

 <TR>
  <TD width="100%">&nbsp;</TD>
 </TR>
 <TR>
  <TD style="border-bottom: #000000 1px solid" nowrap><B>&nbsp;</B></TD>
 </TR>
 <TR>
  <TD nowrap>(Former name or former address if changed since last report.)</TD>
 </TR>

</TABLE>


<P style="font-size: 10pt" align="left">Check the appropriate box below if the
Form 8-K filing is intended to simultaneously satisfy the filing obligation of
the registrant under any of the following provisions:

<P style="font-size: 10pt" align="left"><FONT face="Wingdings">o</FONT> Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)<BR>
<BR>
<FONT face="Wingdings">o</FONT> Soliciting material pursuant
to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)<BR>
<BR>
<FONT
face="Wingdings">o</FONT> Pre-commencement communications pursuant to Rule
14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))<BR>
<BR>
<FONT
face="Wingdings">o</FONT> Pre-commencement communications pursuant to Rule
13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))<BR>


<DIV
style="margin-top: 10pt; font-size: 1pt; width: 100%; border-bottom: black 1pt solid">&nbsp;</DIV>
<DIV
style="font-size: 1pt; width: 100%; border-bottom: black 2pt solid">&nbsp;</DIV>
</DIV>
<P style="font-size: 10pt" align="center">&nbsp;

<P style="display: none; font-size: 10pt" align="center">1
<P style="font-size: 10pt" align="center">&nbsp;
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV
style="margin-left: 0.25in; width: 7.2in; font-family: 'Times New Roman',Times,serif">

<P style="font-size: 10pt" align="left"><B>Item&nbsp;1.01 Entry into a Material
Definitive Agreement.</B>

<P style="font-size: 10pt" align="left">On November&nbsp;26, 2008, the
registrant, EpiCept Corporation (the &#8220;Company&#8221;), entered into an
amendment to the repayment agreement with Technologie-Beteiligungs Gesellschaft
mbH der Deutschen Ausgleichsbank (&#8220;tbg&#8221;).

<P style="font-size: 10pt" align="left">In August&nbsp;1997, EpiCept GmbH, a
wholly-owned subsidiary of the Company, entered into a ten-year non-amortizing
loan in the amount of <FONT
face="'Times New Roman',times,serif">&#8364;</FONT>1.5&nbsp;million with tbg.
The loan initially bore interest at a rate of 6% per annum.

<P style="font-size: 10pt" align="left">In December&nbsp;2007, pursuant to the
terms of a repayment agreement, the Company agreed to repay to tbg
approximately <FONT face="'Times New Roman',times,serif">&#8364;</FONT>0.2
million on December&nbsp;31, 2007, representing all interest payable to tbg as
of that date. The remaining loan balance of <FONT
face="'Times New Roman',times,serif">&#8364;</FONT>1.5&nbsp;million, plus
accrued interest at a rate of 7.38% per annum beginning January&nbsp;1, 2008,
was to be due to tbg no later than June&nbsp;30, 2008.
Tbg also waived
certain additional interest payments of approximately <FONT
face="'Times New Roman',times,serif">&#8364;</FONT>0.5&nbsp;million provided
for in the loan agreement.

<P style="font-size: 10pt" align="left">Pursuant to an amendment to the
December&nbsp;2007 repayment agreement, tbg agreed to allow the Company to
repay the remaining loan balance of <FONT
face="'Times New Roman',times,serif">&#8364;</FONT>1.5&nbsp;million plus
accrued interest to tbg no later than December&nbsp;31, 2008, so long as the
Company paid to tbg <FONT
face="'Times New Roman',times,serif">&#8364;</FONT>56,000, the interest accrued
between January&nbsp;1, 2008 and June&nbsp;30, 2008, no later than July&nbsp;1,
2008.

<P style="font-size: 10pt" align="left">Pursuant to a second amendment to the
December&nbsp;2007 repayment agreement, tbg agreed to allow the Company to
repay the remaining loan balance of <FONT
face="'Times New Roman',times,serif">&#8364;</FONT>1.5&nbsp;million plus
accrued interest to tbg no later than June&nbsp;30, 2009, so long as the
Company pays to tbg approximately <FONT
face="'Times New Roman',times,serif">&#8364;</FONT>56,000, the interest accrued
between July&nbsp;1, 2008 and December&nbsp;31, 2008.

<P style="font-size: 10pt" align="left">A copy of the second amendment to the
repayment agreement is attached hereto and incorporated herein by reference as
Exhibit 10.1.

<P style="font-size: 10pt" align="left"><B>Item&nbsp;2.03. Creation of a Direct
Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of
a Registrant.</B>

<P style="font-size: 10pt" align="left">The information required by
Item&nbsp;2.03 is contained in Item&nbsp;1.01 and is incorporated herein by
reference.

<P style="font-size: 10pt" align="left"><B>Item&nbsp;9.01 Financial Statement
and Exhibits.</B>

<P style="font-size: 10pt" align="left">(d)&nbsp;Exhibits.

<P>
<TABLE style="font-size: 10pt" cellspacing="0" cellpadding="0" width="100%"
border="0">

 <TR
style="font-size: 10pt; background: none transparent scroll repeat 0% 0%; color: #000000"
valign="top">
  <TD style="background: none transparent scroll repeat 0% 0%"
width="4%">&nbsp;</TD>
  <TD nowrap align="left" width="3%">10.1</TD>
  <TD width="1%">&nbsp;</TD>
  <TD>Amendment to the Repayment Agreement, dated November&nbsp;26, 2008.</TD>
 </TR>

</TABLE>




<P style="font-size: 10pt" align="center">2
<P style="font-size: 10pt" align="center">&nbsp;
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV
style="margin-left: 0.25in; width: 7.2in; font-family: 'Times New Roman',Times,serif">


<P style="font-size: 10pt" align="center"><B>SIGNATURES</B>

<P style="font-size: 10pt; text-indent: 4%" align="left">Pursuant to the
requirements of the Securities Exchange Act of 1934, the registrant has duly
caused this report to be signed on its behalf by the undersigned hereunto duly
authorized.

<P style="font-size: 10pt; text-indent: 47%" align="left">EPICEPT CORPORATION
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" cellpadding="0" width="100%"
border="0">
<!-- Begin Table Head -->

 <TR valign="bottom">
  <TD width="45%">&nbsp;</TD>
  <TD width="50%">&nbsp;</TD>
 </TR>
<!-- End Table Head -->

<!-- Begin Table Body -->
 <TR valign="bottom">
  <TD>&nbsp;</TD>
  <TD style="border-bottom: #000000 1px solid" valign="top" align="left">/s/ <FONT style="font-variant: small-caps">Robert W. Cook</FONT></TD>
 </TR>

 <TR valign="bottom">
  <TD>&nbsp;</TD>
  <TD align="left" valign="top">Name: Robert W. Cook</TD>
 </TR>


 <TR valign="bottom">
  <TD>&nbsp;</TD>
  <TD align="left" valign="top">Title: Chief Financial Officer</TD>
 </TR>
<!-- End Table Body -->

</TABLE>
</DIV>

<P style="font-size: 10pt" align="left">Date: December&nbsp;1, 2008

<P style="font-size: 10pt" align="center">3
<P style="font-size: 10pt" align="center">&nbsp;
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="margin-left: 0.25in; width: 7.2in; font-family: 'Times New Roman',Times,serif">

<P style="font-size: 10pt" align="center"><B>EXHIBIT INDEX</B>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" cellpadding="0" width="100%" border="0">
<!-- Begin Table Head -->

 <TR valign="bottom">
  <TD width="8%">&nbsp;</TD>
  <TD width="5%">&nbsp;</TD>
  <TD width="87%">&nbsp;</TD>
 </TR>

 <TR style="font-size: 10pt" valign="bottom">
  <TD style="border-bottom: #000000 1px solid" nowrap align="left"><B>Exhibit</B></TD>
  <TD>&nbsp;</TD>
  <TD style="border-bottom: #000000 1px solid" nowrap align="center"><B>Description</B></TD>
 </TR>
<!-- End Table Head -->

<!-- Begin Table Body -->
 <TR valign="bottom">
  <TD valign="top">10.1</TD>
  <TD>&nbsp;</TD>
  <TD valign="top" align="left">Amendment to the Repayment
Agreement, dated November&nbsp;26, 2008.</TD>
 </TR>
<!-- End Table Body -->

</TABLE>
</DIV>


<P style="font-size: 10pt" align="center">4

<P style="font-size: 10pt" align="center">&nbsp;

</DIV>
</BODY>
</HTML>
[{"type": "8-K", "sequence": "1", "filename": "c77903e8vk.htm", "description": "FORM 8-K", "secsgml_size_bytes": 10564}]
{"company-data": {"conformed-name": "EPICEPT CORP", "cik": "0001208261", "assigned-sic": "2834", "irs-number": "000000000", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-51290", "film-number": "081226753"}, "business-address": {"street1": "777 OLD SAW MILL RIVER RD.", "city": "TARRYTOWN", "state": "NY", "zip": "10591", "phone": "914-606-3500"}, "mail-address": {"street1": "777 OLD SAW MILL RIVER RD.", "city": "TARRYTOWN", "state": "NY", "zip": "10591"}}
Filed by Bowne Pure Compliance
UNITED STATES
SECURITIES AND
EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to
Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest
event reported): November 26, 2008
EPICEPT CORPORATION
(Exact name of registrant as specified in its charter)
Delaware
000-51290
52-1841431
(State or other Jurisdiction of Incorporation)
(Commission File Number)
(IRS Employer Identification No.)
777 Old Saw Mill River
Road
Tarrytown, New York
10591
(Address of Principal Executive Offices)
(Zip Code)
Registrant's telephone number,
including area code:
(914) 606-3500
(Former name or former address if changed since last report.)
Check the appropriate box below if the
Form 8-K filing is intended to simultaneously satisfy the filing obligation of
the registrant under any of the following provisions:
o
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
o
Soliciting material pursuant
to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o
Pre-commencement communications pursuant to Rule
14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o
Pre-commencement communications pursuant to Rule
13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 1.01 Entry into a Material
Definitive Agreement.
On November 26, 2008, the
registrant, EpiCept Corporation (the "Company"), entered into an
amendment to the repayment agreement with Technologie-Beteiligungs Gesellschaft
mbH der Deutschen Ausgleichsbank ("tbg").
In August 1997, EpiCept GmbH, a
wholly-owned subsidiary of the Company, entered into a ten-year non-amortizing
loan in the amount of
€
1.5 million with tbg.
The loan initially bore interest at a rate of 6% per annum.
In December 2007, pursuant to the
terms of a repayment agreement, the Company agreed to repay to tbg
approximately
€
0.2
million on December 31, 2007, representing all interest payable to tbg as
of that date. The remaining loan balance of
€
1.5 million, plus
accrued interest at a rate of 7.38% per annum beginning January 1, 2008,
was to be due to tbg no later than June 30, 2008.
Tbg also waived
certain additional interest payments of approximately
€
0.5 million provided
for in the loan agreement.
Pursuant to an amendment to the
December 2007 repayment agreement, tbg agreed to allow the Company to
repay the remaining loan balance of
€
1.5 million plus
accrued interest to tbg no later than December 31, 2008, so long as the
Company paid to tbg
€
56,000, the interest accrued
between January 1, 2008 and June 30, 2008, no later than July 1,
2008.
Pursuant to a second amendment to the
December 2007 repayment agreement, tbg agreed to allow the Company to
repay the remaining loan balance of
€
1.5 million plus
accrued interest to tbg no later than June 30, 2009, so long as the
Company pays to tbg approximately
€
56,000, the interest accrued
between July 1, 2008 and December 31, 2008.
A copy of the second amendment to the
repayment agreement is attached hereto and incorporated herein by reference as
Exhibit 10.1.
Item 2.03. Creation of a Direct
Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of
a Registrant.
The information required by
Item 2.03 is contained in Item 1.01 and is incorporated herein by
reference.
Item 9.01 Financial Statement
and Exhibits.
(d) Exhibits.
10.1
Amendment to the Repayment Agreement, dated November 26, 2008.
2
SIGNATURES
Pursuant to the
requirements of the Securities Exchange Act of 1934, the registrant has duly
caused this report to be signed on its behalf by the undersigned hereunto duly
authorized.
EPICEPT CORPORATION
/s/
Robert W. Cook
Name: Robert W. Cook
Title: Chief Financial Officer
Date: December 1, 2008
3
EXHIBIT INDEX
Exhibit
Description
10.1
Amendment to the Repayment
Agreement, dated November 26, 2008.
4